Target Name: CHPT1
NCBI ID: G56994
Review Report on CHPT1 Target / Biomarker Content of Review Report on CHPT1 Target / Biomarker
CHPT1
Other Name(s): hCPT1 | Phosphatidylcholine synthesizing enzyme | CPT1 | Choline phosphotransferase 1 | CPT | phosphatidylcholine synthesizing enzyme | Cholinephosphotransferase 1 | choline phosphotransferase 1 | Diacylglycerol cholinephosphotransferase 1 | cholinephosphotransferase 1 alpha | CHPT1_HUMAN | diacylglycerol cholinephosphotransferase 1 | AAPT1-like protein | Cholinephosphotransferase 1 alpha

CHPT1: Role in Pregnancy Development and Maintenance

CHPT1, also known as hCPT1, is a protein that is expressed in the human placenta and has been shown to play a role in the development and maintenance of pregnancy. The protein is composed of 154 amino acids and has a calculated molecular weight of 19.9 kDa.

One of the key functions of CHPT1 is its role in cell signaling. The protein is involved in the FGF signaling pathway, which is a critical pathway that regulates cell growth, differentiation, and survival. During pregnancy, CHPT1 helps to regulate the growth and development of the placenta, and is thought to play a key role in ensuring that the placenta provides a supportive environment for the growing fetus.

Another function of CHPT1 is its role in the regulation of cell adhesion. The protein is involved in the cadherin adhesion molecule, which is a critical protein that helps to maintain the integrity of tissues and organs. During pregnancy, CHPT1 helps to regulate the adhesion of the placenta to the uterine wall, ensuring that the placenta is able to provide a stable and supportive environment for the growing fetus.

CHPT1 is also involved in the regulation of the immune response. The protein is thought to play a key role in the regulation of T cell development and function, and is also involved in the regulation of the production of antibodies. During pregnancy, CHPT1 helps to ensure that the placenta is able to provide a supportive environment for the growing fetus, while also helping to protect the fetus from the immune system.

In addition to its role in cell signaling and cell adhesion, CHPT1 is also involved in the regulation of inflammation. The protein is involved in the regulation of the production of pro-inflammatory cytokines, which are important for the regulation of immune responses and inflammation. During pregnancy, CHPT1 helps to ensure that the placenta is able to provide a supportive environment for the growing fetus, while also helping to protect the fetus from the immune system.

CHPT1 is also involved in the regulation of cellular processes such as cell division, apoptosis, and autophagy. The protein is involved in the regulation of cell division, helping to ensure that cells are able to divide and grow properly. During pregnancy, CHPT1 helps to ensure that the placenta is able to provide a supportive environment for the growing fetus, while also helping to protect the fetus from the immune system.

In conclusion, CHPT1 is a protein that plays a critical role in the development and maintenance of pregnancy. The protein is involved in the FGF signaling pathway, cell signaling and adhesion, immune response, and inflammation. It is also involved in the regulation of cellular processes such as cell division, apoptosis, and autophagy. Therefore, CHPT1 may be a drug target or biomarker for future pregnancy-related studies.

Protein Name: Choline Phosphotransferase 1

Functions: Catalyzes phosphatidylcholine biosynthesis from CDP-choline. It thereby plays a central role in the formation and maintenance of vesicular membranes

The "CHPT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHPT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CHRAC1 | CHRD | CHRDL1 | CHRDL2 | CHRFAM7A | CHRM1 | CHRM2 | CHRM3 | CHRM3-AS2 | CHRM4 | CHRM5 | CHRNA1 | CHRNA10 | CHRNA2 | CHRNA3 | CHRNA4 | CHRNA5 | CHRNA6 | CHRNA7 | CHRNA9 | CHRNB1 | CHRNB2 | CHRNB3 | CHRNB4 | CHRND | CHRNE | CHRNG | Chromobox protein homolog | Chromodomain Helicase DNA Binding Protein | Chromosome 10 open reading frame 115 | Chromosome 16 open reading frame 47 | Chromosome 17 open reading frame 47 | Chromosome 6 open reading frame 183 | CHROMR | CHST1 | CHST10 | CHST11 | CHST12 | CHST13 | CHST14 | CHST15 | CHST2 | CHST3 | CHST4 | CHST5 | CHST6 | CHST7 | CHST8 | CHST9 | CHSY1 | CHSY3 | CHTF18 | CHTF8 | CHTOP | CHUK | CHURC1 | CHURC1-FNTB | Chymotrypsin | CIAO1 | CIAO2A | CIAO2AP2 | CIAO2B | CIAO3 | CIAPIN1 | CIART | CIB1 | CIB2 | CIB3 | CIB4 | CIBAR1 | CIBAR1-DT | CIBAR1P1 | CIBAR1P2 | CIBAR2 | CIC | CICP10 | CICP11 | CICP17 | CICP25 | CICP5 | CICP7 | CIDEA | CIDEB | CIDEC | CIDECP1 | CIITA | CILK1 | CILP | CILP2 | CINP | CIP2A | CIPC | CIR1 | CIRBP | CIRBP-AS1 | CIROP | CISD1 | CISD1P1 | CISD2 | CISD3